NeueHealth reports Q4 EPS ($1.94) vs. ($30.47) last year
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 20 2025
0mins
Q4 Financial Performance: The company reported Q4 revenue of $232.64 million, a decrease from $292.87 million the previous year, but highlighted strong overall financial performance in 2024.
Future Growth Plans: CEO Mike Mikan expressed optimism for 2025, focusing on expanding consumer services and strengthening relationships with payors and providers to enhance coordinated care experiences.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
